NO20052730D0 - Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser - Google Patents
Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelserInfo
- Publication number
- NO20052730D0 NO20052730D0 NO20052730A NO20052730A NO20052730D0 NO 20052730 D0 NO20052730 D0 NO 20052730D0 NO 20052730 A NO20052730 A NO 20052730A NO 20052730 A NO20052730 A NO 20052730A NO 20052730 D0 NO20052730 D0 NO 20052730D0
- Authority
- NO
- Norway
- Prior art keywords
- aminoalkoxy
- indoles
- treatment
- receptor ligands
- cns disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43050602P | 2002-12-03 | 2002-12-03 | |
PCT/EP2003/013372 WO2004050085A1 (en) | 2002-12-03 | 2003-11-27 | Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052730D0 true NO20052730D0 (no) | 2005-06-07 |
NO20052730L NO20052730L (no) | 2005-08-23 |
Family
ID=32469485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052730A NO20052730L (no) | 2002-12-03 | 2005-06-07 | Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser |
Country Status (24)
Country | Link |
---|---|
US (1) | US7084169B2 (no) |
EP (1) | EP1569638B1 (no) |
JP (1) | JP4339795B2 (no) |
KR (1) | KR100755580B1 (no) |
CN (1) | CN1713908B (no) |
AR (1) | AR042155A1 (no) |
AT (1) | ATE372113T1 (no) |
AU (1) | AU2003289903B2 (no) |
BR (1) | BR0316962A (no) |
CA (1) | CA2508315A1 (no) |
DE (1) | DE60316180T2 (no) |
ES (1) | ES2291722T3 (no) |
HR (1) | HRP20050457A2 (no) |
MX (1) | MXPA05005790A (no) |
MY (1) | MY138466A (no) |
NO (1) | NO20052730L (no) |
NZ (1) | NZ539950A (no) |
PA (1) | PA8589801A1 (no) |
PE (1) | PE20040763A1 (no) |
PL (1) | PL377464A1 (no) |
RU (1) | RU2350602C2 (no) |
TW (1) | TWI284124B (no) |
WO (1) | WO2004050085A1 (no) |
ZA (1) | ZA200504412B (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5417142A (en) * | 1992-12-18 | 1995-05-23 | Caterpillar Inc. | Hydraulic amplifier |
JP4455064B2 (ja) | 2002-03-27 | 2010-04-21 | グラクソ グループ リミテッド | キノリン誘導体および5−ht6リガンドとしてのその使用 |
ATE313532T1 (de) | 2003-07-22 | 2006-01-15 | Arena Pharm Inc | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen |
GB0500604D0 (en) * | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
US20090221644A1 (en) * | 2005-06-30 | 2009-09-03 | Stuart Edward Bradley | Gpcr Agonists |
AU2006280091A1 (en) * | 2005-08-15 | 2007-02-22 | Wyeth | Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
MX2008009022A (es) * | 2006-01-13 | 2008-09-24 | Wyeth Corp | 1h-indoles sustituidos por sulfonilo como ligandos para los receptores 5-hidroxitriptamina. |
MX2008013053A (es) | 2006-04-12 | 2008-10-17 | Wyeth Corp | Derivados de dihidri[1,4]oxazino[2,3,4-hi]indazol-sustituidos como ligandos de 5-hidroxitriptamina-6. |
US20100041672A1 (en) * | 2007-03-21 | 2010-02-18 | Glaxo Group Limited | Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome |
WO2009074607A1 (en) | 2007-12-12 | 2009-06-18 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
CN102558020B (zh) * | 2011-12-12 | 2013-09-18 | 温州大学 | 一种3-芳巯基吲哚类化合物的合成方法 |
CN103288707B (zh) * | 2013-05-28 | 2015-12-23 | 浙江大学 | 一种3-苯巯基吲哚衍生物的制备方法 |
AU2015286049B2 (en) | 2014-07-08 | 2018-03-01 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
WO2016201373A1 (en) | 2015-06-12 | 2016-12-15 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder |
CN108472285A (zh) | 2015-07-15 | 2018-08-31 | 阿速万科学有限责任公司 | 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1139760A (en) | 1979-03-07 | 1983-01-18 | Makiko Sakai | 1,4-dioxaspiro¬4,5| decene compounds |
FR2589863B1 (fr) | 1985-11-12 | 1988-07-29 | Sanofi Sa | Derives d'hydroxy-4 indole, leur procede de preparation et leur utilisation |
US5254595A (en) | 1988-12-23 | 1993-10-19 | Elf Sanofi | Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them |
US4939138A (en) * | 1988-12-29 | 1990-07-03 | Sterling Drug Inc. | 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines |
FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
CA2264080A1 (en) * | 1996-08-27 | 1998-03-05 | Richard Eric Mewshaw | 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands |
GB9902452D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
FR2791344B1 (fr) | 1999-03-25 | 2002-02-15 | Adir | Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2793793B1 (fr) | 1999-05-19 | 2004-02-27 | Adir | Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
TWI222450B (en) * | 1999-07-28 | 2004-10-21 | Upjohn Co | Oxazinocarbazoles for the treatment of CNS diseases |
TW593278B (en) | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
US6831094B2 (en) * | 2001-04-20 | 2004-12-14 | Wyeth | Heterocyclylalkoxy-,-alkylthio-and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
-
2003
- 2003-11-27 NZ NZ539950A patent/NZ539950A/en unknown
- 2003-11-27 RU RU2005121125/04A patent/RU2350602C2/ru not_active IP Right Cessation
- 2003-11-27 DE DE60316180T patent/DE60316180T2/de not_active Expired - Lifetime
- 2003-11-27 WO PCT/EP2003/013372 patent/WO2004050085A1/en active IP Right Grant
- 2003-11-27 BR BR0316962-6A patent/BR0316962A/pt not_active IP Right Cessation
- 2003-11-27 JP JP2004556206A patent/JP4339795B2/ja not_active Expired - Fee Related
- 2003-11-27 AT AT03782240T patent/ATE372113T1/de not_active IP Right Cessation
- 2003-11-27 CN CN2003801040190A patent/CN1713908B/zh not_active Expired - Fee Related
- 2003-11-27 TW TW092133339A patent/TWI284124B/zh not_active IP Right Cessation
- 2003-11-27 KR KR1020057010127A patent/KR100755580B1/ko not_active IP Right Cessation
- 2003-11-27 AU AU2003289903A patent/AU2003289903B2/en not_active Ceased
- 2003-11-27 PL PL377464A patent/PL377464A1/pl not_active Application Discontinuation
- 2003-11-27 MX MXPA05005790A patent/MXPA05005790A/es active IP Right Grant
- 2003-11-27 EP EP03782240A patent/EP1569638B1/en not_active Expired - Lifetime
- 2003-11-27 CA CA002508315A patent/CA2508315A1/en not_active Abandoned
- 2003-11-27 ES ES03782240T patent/ES2291722T3/es not_active Expired - Lifetime
- 2003-11-28 PE PE2003001211A patent/PE20040763A1/es not_active Application Discontinuation
- 2003-11-28 PA PA20038589801A patent/PA8589801A1/es unknown
- 2003-12-01 US US10/724,683 patent/US7084169B2/en not_active Expired - Fee Related
- 2003-12-01 AR ARP030104414A patent/AR042155A1/es unknown
- 2003-12-02 MY MYPI20034589A patent/MY138466A/en unknown
-
2005
- 2005-05-24 HR HR20050457A patent/HRP20050457A2/hr not_active Application Discontinuation
- 2005-05-30 ZA ZA200504412A patent/ZA200504412B/en unknown
- 2005-06-07 NO NO20052730A patent/NO20052730L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200504412B (en) | 2006-04-26 |
CN1713908B (zh) | 2010-05-12 |
AR042155A1 (es) | 2005-06-08 |
KR100755580B1 (ko) | 2007-09-06 |
TW200413312A (en) | 2004-08-01 |
US20040132799A1 (en) | 2004-07-08 |
MY138466A (en) | 2009-06-30 |
NZ539950A (en) | 2007-05-31 |
JP4339795B2 (ja) | 2009-10-07 |
DE60316180D1 (de) | 2007-10-18 |
AU2003289903B2 (en) | 2008-06-26 |
PL377464A1 (pl) | 2006-02-06 |
KR20050084155A (ko) | 2005-08-26 |
PE20040763A1 (es) | 2004-11-20 |
BR0316962A (pt) | 2005-10-25 |
CN1713908A (zh) | 2005-12-28 |
EP1569638B1 (en) | 2007-09-05 |
MXPA05005790A (es) | 2005-10-18 |
ES2291722T3 (es) | 2008-03-01 |
DE60316180T2 (de) | 2008-05-29 |
JP2006509777A (ja) | 2006-03-23 |
NO20052730L (no) | 2005-08-23 |
EP1569638A1 (en) | 2005-09-07 |
US7084169B2 (en) | 2006-08-01 |
ATE372113T1 (de) | 2007-09-15 |
RU2350602C2 (ru) | 2009-03-27 |
TWI284124B (en) | 2007-07-21 |
RU2005121125A (ru) | 2006-02-20 |
WO2004050085A1 (en) | 2004-06-17 |
HRP20050457A2 (en) | 2005-10-31 |
PA8589801A1 (es) | 2004-11-26 |
CA2508315A1 (en) | 2004-06-17 |
AU2003289903A1 (en) | 2004-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052730D0 (no) | Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser | |
IL182365A0 (en) | 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders | |
DK1656346T3 (da) | 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme | |
IS7099A (is) | Efnasambönd til að meðhöndla bólgutruflanir | |
NO20053211D0 (no) | Forbindelser for behandling av metabolske forstyrrelser. | |
NO20014047D0 (no) | Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser | |
AP2005003283A0 (en) | Indole derivatives useful for the treatment os diseases | |
NO20043237L (no) | Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser | |
NO20052223D0 (no) | Tiazolforbindelser for behandling av neurodegenerative forstyrrelser | |
CY2013022I1 (el) | Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
IS2907B (is) | Bensó[d]asepínafleiður til að meðhöndla taugakvilla | |
PL1833799T3 (pl) | 3-Fenylo-pirazolowe pochodne jako modulatory 5-HT2A receptora serotoniny użyteczne w leczeniu zaburzeń związanych z tym receptorem | |
NO20050136D0 (no) | Fremgangsmate for fremstilling av mikropartikler | |
SE0202241D0 (sv) | Novel Compounds | |
DK1551860T3 (da) | Glukokortikoid-receptorligander til behandling af stofskifteforstyrrelser | |
IS7202A (is) | Samsetningar til meðhöndlunar á ónæmisbólgusjúkdómum | |
DK1491212T3 (da) | Middel til behandling af søvnforstyrrelser | |
PL374401A1 (en) | 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders | |
NO20033417L (no) | Anvendelse av CD23-antagonister for behandling av neoplastiske forstyrrelser | |
NO20052471D0 (no) | Fremgangsmate for fremstilling av 3-metyltiopropanal. | |
NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
NO20050885D0 (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
NO20052012L (no) | Indoler nyttige for behadling av androgen-reseptor relaterte sykdommer | |
NO20026005D0 (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
DK1121356T3 (da) | 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |